Agilent Q4 Revenues Climb 35 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today reported revenues for its fiscal 2010 fourth quarter of $1.58 billion, up 35 percent from a year ago and surpassing analyst estimates of $1.52 billion.

A year ago, the company posted revenues $1.17 billion. Excluding the effects of the Varian acquisition and recent divestitures, revenues for the three months ended Oct. 31 were up 26 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.